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Requirements (STR) is a short document outlining the required 
elements of training which are: a five year (ie time based) training 
period incorporating a variety of clinical rotations, successful 
completion of the certification examination, and completion of a 
scholarly project.  
http://rcpsc.medical.org/residency/certification/training/rad-
oncology_e.pdf  
The Objectives of Training (OTR) is a fairly lengthy document 
describing the competencies that must be attained during training. 




Each university training program is responsible for ensuring that it 
provides an academic and clinical environment for each trainee to 
attain all CanMEDS competencies as described in the OTR and STR. 
The third standard of training is the Specific Standards of 
Accreditation (SSA) which describes the necessary structure and 
resources which must be in place to operate a training program. There 
are six Standards described in the SSA document, 
http://rcpsc.medical.org/residency/accreditation/ssas/radonc_e.pdf 
each of which is described in further detail in the RCPSC General 
Standards of Accreditation Applicable to All Residency Programs 
(otherwise known as the Blue Book).  
Extensive documentation is required to describe the administrative 
structure, goals and objectives, structure and organization of the 
program, resources, program content, and assessment of resident 
performance. All of this information is detailed in a document called 
the Program Specific Questionnaire (PSQ), a two part document. 
To confirm that programs are delivering training that meets the 
requirements as set forth by the RCPSC and specialty committee, an 
‘external’ survey is conducted every six years with an ‘internal’ 
survey in the interval three years. Deficiencies in any element of the 
three overall standards of training is cited, and must be corrected. 
The audit processes are labour intensive and time consuming.  
Curriculum renewal is a constant process and the RCPSC is in the early 
stages of revising the CanMEDS framework to incorporate metrics such 
as Entrustable Professional Activities (EPA’s) and milestones to better 
articulate physician competencies. In addition, a variety of 
stakeholders have come together to articulate a vision for post-
graduate medical education in the 21st century.  
http://www.afmc.ca/future-of-medical-education-in-
canada/postgraduate-project/pdf/FMEC_PG_Final-Report_EN.pdf 
Within this strategy, physician mix and distribution is identified as an 
important element to address at the post-graduate training level. 
While work force planning has never been a component of any of the 
RCPSC specialty training requirements,there is recognition that the 
human resource and cost investment associated with training specialty 
physicians must address this issue. Due to a scarcity of employment 
opportunities in radiation oncology in Canada, radiation oncology 
program directors across the country agreed three years ago to limit 
the total number of first year training positions to 25 per year. In 
many centres, there is only one trainee accepted into training each 
year. Whether this leads to a shortage of radiation oncologists in the 
next 3-5 years remains to be seen. 
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Cervical cancer staging still depends on physical examination, with 
FIGO categorization. Since 2009, FIGO committee recommends 
imaging modalities such as CT and MRI to optimize staging accuracy. 
MRI should be promoted to perform cervical cancer staging in 
comparison to CT. Nevertheless, CT may still be used if MRI is not 
available. Quality of image acquisition and reporting is mandatory to 
help to define FIGO stage and treatment decision. Images must be 
acquired from symphysis until left renal vein, to analyse tumor 
characteristics, pelvic and retroperitoneal lymph nodes which are the 
most frequently invaded lymph nodes. A complete report must 
include : tumour size and invasion of adjacent organs (bladder, 
cervical stroma, isthmus, rectum, parametrium), and lymph node 
status. 
Modern MRI should include Diffusion-weighted images (DWI) which 
could help to reduce the number of false positives in tumour response 
evaluation after chemoradiation therapy ; residual tumour average 
diffusion coefficient (ADC) has been shown to be lower than ADC of 
inflammatory changes after treatment. For lymph node evaluation, 
DWI is definitely not accurate to characterize benign and malignant 
lymph nodes, as all LN present a bright signal. 
For tumour response evaluation, dynamic sequences after contrast 
injection may help to delineate cervical tumour from cervical stroma 
and changes after treatment. Some studies underlined the role of 
dynamic and perfusion MRI to predict treatment efficacy in measuring 
lesion vascularization, cellular density and pO2 measurement. Even if 
angiogenesis seem to be correlated to pO2 and cell density, these 
parameters seem not accurate enough to decide invidual treatment 
plan. 
MRI may be used more accurately as CT to plan brachytherapy,as 
delineation of cervical tumour and adjacent organs is much more 
clearly visible. 
PET should be performed in cervical cancer staging, especially for 
tumour > Ib1 to define lymph node status, as MRI is limited in this 
indication. PET sensitivity and specificity are much higher to MRI for 
pelvic and abdominal LN. Nevertheless, as 10-15 % of false negatives 
LN are encoutered in a normal PET, abdominal LN dissection is still 
recommended in case of normal PET. 
Future imaging will probably be greatly improved with the use of PET-
MRI, which will include advantages of both MRI and PET.  
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Intensity modulated radiation therapy (IMRT) is an emerging technique 
which has been shown to be effective inpreventing xerostomia in head 
and neck cancer and proctitis in prostate cancer.Therefore, it  can be 
considered as the standard treatment in all pelvic tumours. In locally 
advanced cervical cancer,its role is still under debate since the target 
volume combines both pelvic lymph node areas and highly mobile 
structures such as the uterus and the cervix itself. Dosimetric studies 
have shown its advantage in decreasing the dose delivered to the 
rectum, small bowel and bladder. However, clinical data is still 
limited and it is still argued that this benefit may be thwarted by the 
margins applied to take into account organ movement and by the fact 
that the uterus “pushes” the small bowel outside of the pelvis. In 
other clinical situations, thebenefit of IMRT seems to be  clearer: 
postoperative radiotherapy where the bowel falls into the pelvis and 
extended field radiotherapy to paraaortic lymph nodes due to an 
increased risk of radiation induced gastrointestinal morbidity and the 
need to avoid the kidneys and the spinal cord. Moreover, IMRT could 
also allow bone marrow preservation which could promote adjuvant 
chemotherapy in high risk patients, a field in which a phase III study 
has just been launched. IMRT is also a solution which allows dose 
escalation to achieve lymph node control. In this particular issue there 
is no standard on the dose required to sterilize metastatic nodes and 
various techniques and dose thresholds are applied. The risk of late 
morbidity induced by boosting lymph nodes is an impediment to dose 
escalation which can now be bypassed by modern radiotherapy 
techniques. Finally the debate could not be definitely closed in the 
absence of a randomized study comparing IMRT and conformal 
radiotherapy. 
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Different traditions and schools worldwide were leading to a great 
heterogeneity in the current practice of cervical cancer 
brachytherapy. The standard procedure consists of x-ray based 
treatment planning based on predefined dose points (point A, ICRU 
points etc.) and dose delivery in afterloading technique. However, the 
use of x-rays and dose points for treatment planning hardly reflects 
the complexity of uterine cervical cancer and the female pelvic 
anatomy and allows for only very limited space for treatment 
individualisation leading to a substantial number of local recurrences 
and severe treatment related morbidity. The need for more 
personalized medicine lead therefore to the development of image-
guided adaptive brachytherapy (IGABT). The conceptual background 
of IGABT was elaborated by the GYN GEC-ESTRO Working Group and 
